Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

NXE vs UROY: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

UROY Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–3 Matrix Metrics)

UROY Overall Winner 6-Pillar Tally: NXE 0 – 5 UROY (1 Tie) Matrix Metrics: NXE 3 – 7 UROY

As of Nov 16, 2026, Uranium Royalty Corp. (UROY) is the stronger overall head-to-head candidate over NexGen Energy Ltd. (NXE) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NXE carries a Unified Composite Score of 54.2/100 (HOLD) at $7.43 (N/M Forward P/E, 0.0% operating margin), whereas UROY carries 44.9/100 (HOLD) at $2.65 (69.5x Forward P/E, 30.2% operating margin).

  • Composite vs. Pillar Nuance: While NXE currently prints a higher short-term Unified Composite Score (54.2/100 HOLD vs. UROY 44.9/100 HOLD), UROY captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (30.2% vs. 0.0% operating margin) and revenue trajectory (+112.9% vs. +0.0% YoY).
  • Technical & Structure Timing Caution: NXE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.0); meanwhile UROY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 28.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NXE vs UROY
NXE NYSE
NexGen Energy Ltd.
Miscellaneous Metal Ores
$7.43
-4.25% 1D
Market Cap $5.3B
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.04β · 55% Vol
Unified Composite Score
54.2 / 100 HOLD
Tech 34.0 Fund 54.0 Flow 58.0 Mom 78.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.6%), weak momentum, RSI 36
RSI-14: 36.0 · SMA20: $8.24 · SMA50: $8.83
UROY NASDAQ Head-to-Head Winner
Uranium Royalty Corp. Common Stock
Commodity Contracts Brokers & Dealers
$2.65
-4.86% 1D
Market Cap $1.1B
TTM Revenue $560M
Forward P/E 69.5x
Beta / 30D Vol 1.93β · 66% Vol
Unified Composite Score
44.9 / 100 HOLD
Tech 25.0 Fund 44.0 Flow 58.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.9%), weak momentum, RSI 28
RSI-14: 28.1 · SMA20: $3.20 · SMA50: $3.78

6-Pillar Scorecard Institutional Category Breakdown (NXE 0 – 5 UROY)

Columns: Metric · NXE · UROY
1. Valuation Multiples UROY
Forward P/E N/M 69.5x
Trailing P/E N/M 7.4x
PEG Ratio N/M N/M
EV / Revenue N/M 4.4x
2. Growth & Scale UROY
Revenue Growth (YoY) +0.0% +112.9%
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) N/A $560M
Market Cap $5.3B $1.1B
3. Profitability & Quality UROY
Gross Margin N/A 33.1%
Operating Margin 0.0% 30.2%
Net Profit Margin 0.0% 25.9%
Return on Equity (ROE) -10.3% 8.5%
4. Balance Sheet & Cash Flow UROY
Cash Generation (TTM) -$418M $544M
Cash Flow Margin N/A 97.3%
Net Cash / Leverage $58M Net Cash $1.41B Net Debt (0.62x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 52.6% (16th %ile) 67.2% (31st %ile)
Put/Call OI Skew 0.70x (Call-Skewed) 0.71x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat UROY
OpEx & R&D Intensity N/A 2.9% of Rev ($16M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Uranium Operator Uranium Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NXE (3) vs UROY (7)
Institutional Metric NXE UROY Criterion Row Edge
Market Capitalization
Scale
$5.3B $1.1B Larger Scale NXE
Trailing P/E Ratio
Valuation
N/M 7.4x Lower Multiple UROY
Forward P/E Ratio
Valuation
N/M 69.5x Lower Multiple UROY
Revenue Growth (YoY)
Growth
+0.0% +112.9% Higher Growth UROY
Operating Margin (TTM)
Profitability
0.0% 30.2% Higher Margin UROY
Net Profit Margin
Profitability
0.0% 25.9% Higher Margin UROY
Return on Equity (ROE)
Capital Efficiency
-10.3% 8.5% Higher ROE UROY
52-Week Range Position
Momentum
2% ($7–$14) 3% ($3–$6) Stronger Trend UROY
Beta / 30D Volatility
Risk Regime
2.04β · 55% Vol 1.93β · 66% Vol Lower Realized Risk NXE
Unified Institutional Score
Composite Signal
54.2 / 100 (HOLD) 44.9 / 100 (HOLD) Higher Composite NXE
Trailing 12M Revenue (USD)
Operating Scale
N/A $560M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 33.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 4.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$418M ($58M Net Cash) $544M ($1.41B Net Debt (0.62x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NXE +14.05 pp
NXE: -11.23% · UROY: -25.28%
3M Horizon NXE +6.95 pp
NXE: -27.58% · UROY: -34.53%
6M Horizon UROY +5.74 pp
NXE: -32.27% · UROY: -26.53%
1Y Horizon NXE +20.35 pp
NXE: -8.16% · UROY: -28.51%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NXE vs UROY. Trailing 12-month operating profitability (NXE 0.0% vs UROY 30.2%) and valuation multiples (NXE N/M vs UROY 69.5x Forward P/E) are benchmarked directly in Pillar 4 below.

NXE ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-10.3% · N/M
UROY ADR TTM Benchmark FX-Normalized USD
TTM Revenue$560M
Gross Margin33.1%
Op. Margin30.2%
ROE / Fwd P/E8.5% · 69.5x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NXE BREAKDOWN
58d in phase · OBV DISTRIBUTION
Current IV 52.6%
IV Percentile 16th %ile
Put/Call OI Skew 0.70x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact NXE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
UROY BREAKDOWN
49d in phase · OBV DISTRIBUTION
Current IV 67.2%
IV Percentile 31st %ile
Put/Call OI Skew 0.71x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact UROY Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NXE Moat Profile Cyclical / Execution-Driven Positioning
Uranium Operator
Competes within the Uranium value chain with $5.3B market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
UROY Moat Profile High-Margin Pricing Power Moat
Uranium Operator
Competes within the Uranium value chain with $1.1B market capitalization and 30.2% operating margin.
OpEx & R&D Reinvestment 2.9% of Rev ($16M)
90D Engineering Disclosures 0 Published

Investor FAQ NXE vs UROY Key Questions & Quantitative Answers

As of Nov 16, 2026, Uranium Royalty Corp. (UROY) is the stronger overall head-to-head candidate over NexGen Energy Ltd. (NXE) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NXE carries a Unified Composite Score of 54.2/100 (HOLD) at $7.43 (N/M Forward P/E, 0.0% operating margin), whereas UROY carries 44.9/100 (HOLD) at $2.65 (69.5x Forward P/E, 30.2% operating margin). Composite vs. Pillar Nuance: While NXE currently prints a higher short-term Unified Composite Score (54.2/100 HOLD vs. UROY 44.9/100 HOLD), UROY captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (30.2% vs. 0.0% operating margin) and revenue trajectory (+112.9% vs. +0.0% YoY). Technical & Structure Timing Caution: NXE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.0); meanwhile UROY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 28.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

UROY leads the Growth & Scale pillar: NXE posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with UROY at +112.9% YoY revenue growth and N/A YoY earnings growth on $560M TTM revenue (33.1% gross margin, 30.2% operating margin). On trailing 12-month operating scale, NXE generates N/A in USD-normalized revenue versus $560M for UROY. In operating R&D and SG&A reinvestment, NXE deploys N/A (0 90-day corporate R&D disclosures) versus 2.9% of Rev ($16M) (0 disclosures) for UROY.

UROY screens cheaper on headline valuation multiples. NXE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas UROY trades at 69.5x Forward P/E, 7.4x Trailing P/E, N/M PEG, and 4.4x EV/Revenue (97.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NXE (-10.3% ROE) versus UROY (8.5% ROE) capital efficiency.

In options market volatility and institutional positioning, NXE carries 52.6% implied volatility (16th %ile, Compressed (<25th %ile)), a 0.70x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.04β · 55% Vol realized risk). By comparison, UROY carries 67.2% implied volatility (31st %ile, Balanced (25th–60th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.93β · 66% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.